Structure-activity relationship studies for multitarget antithrombotic drugs.

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Biochemistry

Background:

• Thrombosis involves complex, multifactorial pathways.
• Current antithrombotic therapy often combines multiple drugs, indicating the benefit of targeting several pathways.
• The limitations of current therapies necessitate novel approaches.

Purpose of the Study:

• To review structure-activity relationship (SAR) studies of molecules with multiple antithrombotic actions.
• To explore dual inhibitors targeting coagulation, platelet aggregation, or both.
• To highlight the potential of multitarget strategies in thrombosis treatment and prevention.

Main Methods:

• Literature review focusing on SAR studies of multitarget antithrombotic agents.
• Categorization of inhibitors based on their dual mechanisms of action.
• Analysis of molecular structures and their corresponding biological activities.

Main Results:

• Identified various classes of dual inhibitors, including those targeting coagulation and platelet aggregation.
• Discussed SAR findings that inform the design of potent and selective multitarget agents.
• Highlighted EP217609 as a promising candidate entering clinical trials.

Conclusions:

• Multitarget strategies offer significant potential for enhanced antithrombotic efficacy.
• SAR studies are crucial for designing effective dual-action antithrombotic drugs.
• The development of novel multitarget agents represents a promising future direction for managing thrombosis.